RE:Hello good people of the BED board
Here is the link to MT finance report.
https://www.mettrum.com/files/MDA-Q3-2015-Feb-11-15-Final.pdf
Mettrum had revenue of $689,478 and $2,211,021, for the three and nine months ended December 31, 2014, respectively. Mettrum temporarily stopped accepting new clients in late June as it reached its production capacity at its existing licensed facility. Mettrum began accepting new, additional patients in January 2015 as a result of improved capacity at its initial facility in Bowmanville, additional capacity from its recently licenced Agripharm facility and an agreement to purchase up to 150 kg of cannabis annually from another licensed MMPR producer. The purchased cannabis is required to meet rigorous quality criteria.
Mettrum has come up fast surprisingly with the biggest revenue ( not full year, only 9 months). I believe sooner or later, Mettrum will be the number one in recreational market. And Bedrocan will be number one in medical market.